[ Price : $8.95]
U.S. Senators Ted Budd (R-NC) and Martin Heinrich (D-NM) introduce a bipartisan amendment to FDAs fiscal year 2026 spending bill t...[ Price : $8.95]
FDA orders new mandatory safety labeling changes for all opioid analgesics, a move aimed at curbing long-term misuse of the produc...[ Price : $8.95]
FDA publishes a guidance explaining the process it uses to determine and qualify a MDUFA small business.[ Price : $8.95]
FDA grants Vivace Therapeutics an orphan drug designation for VT3989 and its use in treating mesothelioma.[ Price : $8.95]
Top House Democrats on the Energy and Commerce Committee raise alarm over what they describe as a coordinated effort by the Trump ...[ Price : $8.95]
FDA issues an online statement summarizing all its concerns with unapproved versions of GLP-1 weight loss drugs being marketed to ...[ Price : $8.95]
AbbVie files a supplemental NDA seeking approval for a new, fixed-duration, all-oral combination regimen of Venclexta (venetoclax)...[ Price : $8.95]
FDA says its Arthritis Advisory Committee is no longer worth the effort and expense needed to maintain it, and it has been termina...